Table 10.
Multidrug resistance patterns for bacteria isolated from medical equipment, inanimate surfaces, and indoor air of the NICU and pediatric ward at HUCSH, October 20 to December 30, 2020 (N = 154).
| Types of bacteria | Types of antibiotic | MDR, n (%) | Total MDR, n (%) |
|---|---|---|---|
| K. pneumoniae (n = 29) | IMP, CIP, TS, CXM | 1 (3.5) | 11 (37.9) |
| CIP, CAZ, CN, CXM | 1 (3.5) | ||
| CZ, CAZ, TS, CXM | 2 (3.5) | ||
| CIP, CZ, TS, CXM | 1 (3.5) | ||
| IMP, CIP, TS, CXM | 1 (3.5) | ||
| CZ, TS, CXM | 1 (3.5) | ||
| CZ, CAZ, TS | 1 (3.5) | ||
| IMP, CIP, CAZ, | 1 (3.5) | ||
| TS, CN, CXM | 1 (3.5) | ||
| CN, CXM, CZ | 1 (3.5) | ||
| K. rhinoscleromatis (n = 23) | AMK, IMP, CIP, CAZ, CN, CZ | 1 (4.3) | 5 (21.7) |
| AMK, CIP, CZ, CAZ, CN | 1 (4.3) | ||
| CIP, CAZ, TS, | 1 (4.3) | ||
| CIP, CZ, TS | 2 (8.7) | ||
| K. oxytoca (n = 15) | CZ, CAZ, TS, CN | 1 (6.7) | 5 (33.3) |
| CIP, CZ, CAZ, CXM | 1 (6.7) | ||
| CIP, CZ, CAZ, CTX | 1 (6.7) | ||
| CZ, TS, CXM | 1 (6.7) | ||
| CIP, CZ, TS | 1 (6.7) | ||
| K. ozaenae (n = 6) | CIP, CZM, TS, | 1 (16.7) | 1 (16.6) |
| Acinetobacter species (n = 39) | AMK, IMP, CXM, CIP, CAZ, CN, CZ | 1 (2.6) | 5 (12.8) |
| AMK, IMP, CIP, CAZ, CXM | 1 (2.6) | ||
| AMK, CIP, CAZ, TS, CN | 1 (2.6) | ||
| AMK, CIP, CAZ, CN | 1 (2.6) | ||
| AMK, IMP, CIP | 1 (2.6) | ||
| Pseudomonas species (n = 23) | IMP, CIP, CAZ, CN | 1 (2.6) | 1 (4.3) |
| S. epidermidis (n = 15) | E, OX, P, FOX | 1 (6.7) | 5 (33.3) |
| DA, E, FOX | 1 (6.7) | ||
| DA, OX, FOX | 3 (20) | ||
| Overall | 33 (21.4) |
HUCSH: Hawassa University Comprehensive Specialized Hospital, AMK: amikacin, IMP: imipenem, CIP: ciprofloxacin, CZ: cefazolin, CAZ: ceftazidime, TS: trimethoprim sulfamethoxazole, CN: gentamicin, CTX: cefotaxime, DA: clindamycin, E: erythromycin, FOX: cefoxitin, P: penicillin G, OX: oxacillin, CXM: cefuroxime.